However, only one relevant study reported its role in tumors, showing that genetic changes in SLC25A17 (CNV deletion) were closely associated with the overall survival rate and relapse-free survival rate of neuroblastoma patients (Khan et al., 2015). The gene discussed is SLC25A17; the disease is neuroblastoma.